TβRIII is induced by TCR signaling and downregulated in FoxP3+ regulatory T cells-Reference-Cited by-同舟云学术

TβRIII is induced by TCR signaling and downregulated in FoxP3+ regulatory T cells

Published:2017-12 Issue:1-2 Volume:494 Page:82-87
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ortega-Francisco Sandra,de la Fuente-Granada Marisol^ORCID,Alvarez Salazar Evelyn K.,Bolaños-Castro Lizbeth Airais,Fonseca-Camarillo Gabriela,Olguin-Alor Roxana,Alemán-Muench Germán R.,López-Casillas Fernando,Raman Chander,García-Zepeda Eduardo A.,Soldevila Gloria

Funder

DGAPA-PAPIIT UNAM

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference29 articles.

1. How to find your way through the thymus: a practical guide for aspiring T cells;Dzhagalov;Cell Mol. Life Sci.,2012

2. TGF-beta: a master of all T cell trades;Li;Cell,2008

3. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A;Esparza-Lopez;J. Biol. Chem.,2001

4. Roles for the type III TGF-beta receptor in human cancer;Gatza;Cell Signal,2010

5. The type III TGFbeta receptor regulates directional migration: new tricks for an old dog;Mythreye;Cell Cycle,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of TGFBR3 in the Development of Lung Cancer;Protein & Peptide Letters;2024-07

2. Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis;Blood;2024-06-20

3. Tumors produce glucocorticoids by metabolite recycling, not synthesis, and activate Tregs to promote growth;Journal of Clinical Investigation;2023-09-15

4. Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAE;Frontiers in Immunology;2023-02-06

5. Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor;Cancer Immunology, Immunotherapy;2022-11-03